Health
Evidence of robust and persistent antibodies against SARS-CoV-2 – News-Medical.Net
A team of researchers from the Icahn School of Medicine at Mount Sinai, New York, have worked in collaboration to try and answer one of the most baffling questions…
A team of researchers from the Icahn School of Medicine at Mount Sinai, New York, have worked in collaboration to try and answer one of the most baffling questions surrounding the coronavirus disease 19 (COVID-19) pandemic: do antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) last after a primary infection? And, if the antibodies remain active, for how long can they be relied upon as protection against the infection? Over 47.3 million people worldwide have been…
-
Noosa News16 hours agoTallest tower outside CBD approved for construction at 205 metres
-
Noosa News21 hours agoTrucking company penalised for refusing to pay unfairly sacked worker
-
General23 hours agoVacherot becomes lowest-ranked ATP Masters winner after defeating his cousin Rinderknech in Shanghai
-
Noosa News17 hours agoFarmgate Backpackers leads with integrity amid industry challenges